Vir Biotechnology Raises More Than $150M To Fight Infectious Disease
San Francisco-based Vir Biotechnology, a new startup which says it is developing cures, treatments, and preventions for challenging infectious diseases, said today that it has raised $150M in funding, and launched the startup. The company is led by former Biogen CEO George Scangos. The funding was led by ARCH Venture Partners and the Bill & Melinda Gates Foundation, and also included un-named sovereign wealth funds, public mutual funds and individuals and family offices.
posted on Friday, January 6, 2017
Related companies:
Vir Biotechnology, Inc.
Related stories:
> IDbyDNA Gets $9M
> Karius Collects $50M For Disease Detection
> Trellis Bioscience Raises $10M
> Box Raises $150M Ahead Of IPO
> Tacere Scores Seed Financing
silicontap.com Home